Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN119409709A details high-yield lornoxicam preparation reducing impurities and enhancing supply chain reliability for pharmaceutical manufacturing.
Patent CN108276233A reveals a novel iron-catalyzed amide synthesis route offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN104130194A reveals a green catalytic hydrogenation route for 5-Amino-2-benzimidazolinone, offering superior purity and supply chain reliability for pharmaceutical manufacturers.
Novel hydrolysis-esterification route for high-purity Cefathiamidine. Reduces costs and improves supply chain stability for pharmaceutical manufacturers.
Patent CN102134265A details a novel 8-step synthesis from estrone. This route offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN107056834A reveals a streamlined MPC synthesis route offering cost reduction and supply chain reliability for high-purity biomedical material manufacturing.
Novel aminotransferase mutant enables 99% ee sitagliptin intermediate. Robust DMSO tolerance ensures cost reduction in pharma manufacturing.
Patent CN108276233A reveals a novel iron-catalyzed amide synthesis route offering cost reduction and supply chain reliability for high-purity pharmaceutical intermediate manufacturing.
Novel zinc-catalyzed route for 3-(4-chlorobutyl)-5-cyanoindole. Avoids Lewis acids, ensures high purity and scalable production for global supply chains.
Patent CN108373424A reveals solvent-free hydrogenation for high-purity dye intermediates ensuring safer production and substantial cost reduction for global supply chains.
Patent CN107501136A reveals metal-free route for gem-diarylmethylamines. Achieve cost reduction and supply stability in pharmaceutical intermediates manufacturing.
Patent CN115093323B enables efficient iridium-catalyzed synthesis of beta-functionalized chiral homoallylic alcohols. Delivers high enantioselectivity and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN102925500A enables high-purity chiral ester synthesis via yeast biocatalysis, offering cost-effective and scalable pharmaceutical intermediate solutions for global supply chains.
Patent CN107501139A reveals water-phase synthesis for gem-diarylmethyl sulfones. Offers green, cost-effective manufacturing for pharmaceutical intermediates supply chains.
Patent CN102675197A details a high-yield, eco-friendly route for Sorafenib intermediate. Reduces solvent use and improves purity for scalable manufacturing.
Novel intramolecular cyclization method for camptothecin intermediates ensures high yield and scalable production for global pharmaceutical supply chains.
Patent CN119912363A reveals a metal-free photoredox method for alpha-aryl cyclic ketones. This breakthrough offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel iridium-catalyzed synthesis offers high enantioselectivity for pharmaceutical intermediates. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN107304176A details a mild chiral synthesis route for alpha-fluoro beta-amino acids, offering high optical purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN113277993A reveals a green 2-step route for Tafamidis derivatives using NaIO4 and KMnO4, offering significant cost reduction in pharmaceutical manufacturing.